S3-Leitlinie Prostatakarzinom - AWMF

9. Literatur
231. Carver BS, Bianco FJ, Jr., Scardino PT, Eastham JA. Long-term outcome following radical
prostatectomy in men with clinical stage T3 prostate cancer. Journal of Urology
2006;176(2):564-8. http://www.ncbi.nlm.nih.gov/pubmed/16813890
232. Edamura K, Saika T, Senoh T, Koizumi F, Manabe D, Ebara S, Kaku H, Yokoyama T, Abarzua
F, Nagai A, Nasu Y, Tsushima T, Kumon H. Long-term clinical outcomes of 420 consecutive
prostate cancer patients in a single institute. Acta Med Okayama 2005;59(5):195-9.
http://www.ncbi.nlm.nih.gov/pubmed/16286958
233. Fletcher SG, Mills SE, Smolkin ME, Theodorescu D. Case-matched comparison of
contemporary radiation therapy to surgery in patients with locally advanced prostate
cancer. Int J Radiat Oncol Biol Phys 2006;66(4):1092-9.
http://www.ncbi.nlm.nih.gov/pubmed/16965872
234. Hachiya T, Akakura K, Saito S, Shinohara N, Sato K, Harada M, Kato T, Okada K. A
retrospective study of the treatment of locally advanced prostate cancer by six institutions
in eastern and north-eastern Japan. BJU Int 2005;95(4):534-40.
http://www.ncbi.nlm.nih.gov/pubmed/15705075
235. Johnstone PA, Ward KC, Goodman M, Assikis V, Petros JA. Radical prostatectomy for clinical
T4 prostate cancer. Cancer 2006;106(12):2603-9.
http://www.ncbi.nlm.nih.gov/pubmed/16700037
236. Saito T, Kitamura Y, Komatsubara S, Matsumoto Y, Sugita T, Hara N. Outcomes of locally
advanced prostate cancer: a single institution study of 209 patients in Japan. Asian J Androl
2006;8(5):555-61. http://www.ncbi.nlm.nih.gov/pubmed/16847528
237. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically
advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-
year outcome. BJU Int 2005;95(6):751-6. http://www.ncbi.nlm.nih.gov/pubmed/15794776
238. Namiki S, Tochigi T, Ishidoya S, Ito A, Numata I, Arai Y. Long-term quality of life following
primary treatment in men with clinical stage T3 prostate cancer. Qual Life Res
2011;20(1):111-8. http://www.ncbi.nlm.nih.gov/pubmed/20680687
239. Amling CL, Leibovich BC, Lerner SE, Bergstralh EJ, Blute ML, Myers RP, Zincke H. Primary
surgical therapy for clinical stage T3 adenocarcinoma of the prostate. Semin Urol Oncol
1997;15(4):215-21. http://www.ncbi.nlm.nih.gov/pubmed/9421448
240. Berglund RK, Jones JS, Ulchaker JC, Fergany A, Gill I, Kaouk J, Klein EA. Radical
prostatectomy as primary treatment modality for locally advanced prostate cancer: a
prospective analysis. Urology 2006;67(6):1253-6.
http://www.ncbi.nlm.nih.gov/pubmed/16678888
241. Freedland SJ, Partin AW, Humphreys EB, Mangold LA, Walsh PC. Radical prostatectomy for
clinical stage T3a disease. Cancer 2007;109(7):1273-8.
http://www.ncbi.nlm.nih.gov/pubmed/17315165
242. Gerber GS, Thisted RA, Chodak GW, Schroder FH, Frohmuller HG, Scardino PT, Paulson DF,
Middleton AW, Jr., Rukstalis DB, Smith JA, Jr., Ohori M, Theiss M, Schellhammer PF. Results
of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional
pooled analysis. Eur Urol 1997;32(4):385-90.
http://www.ncbi.nlm.nih.gov/pubmed/9412793
243. Ham WS, Park SY, Rha KH, Kim WT, Choi YD. Robotic radical prostatectomy for patients with
locally advanced prostate cancer is feasible: results of a single-institution study. J
Laparoendosc Adv Surg Tech A 2009;19(3):329-32.
http://www.ncbi.nlm.nih.gov/pubmed/19397390
© Leitlinienprogramm Onkologie | S3-Leitlinie Prostatakarzinom | Version 2.0, 1. Aktualisierung 2011